Evidence map›Paper›PMID 37941643›Full record

ArticleAmerican journal of clinical and experimental urology2023

27-year trends in incidence rates for testis cancer across a large statewide registry.

Ahmad N Alzubaidi, Stephen Sekoulopoulos, Jonathan T Pham, Amy Zheng, Mashtura Hasan, Vonn Walter, Jay G Fuletra, Jay D Raman

Abstract read
PubMed Full text at PMC
In one paragraph

Article in American journal of clinical and experimental urology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ahmad N AlzubaidiDepartment of Urology, Penn State Health Milton S. Hershey Medical Center 500 University Drive, Hershey, PA, USA.
Stephen SekoulopoulosPenn State College of Medicine, Penn State Health Milton S. Hershey Medical Center 700 HMC Crescent Road, Hershey, PA, USA.
Jonathan T PhamPenn State College of Medicine, Penn State Health Milton S. Hershey Medical Center 700 HMC Crescent Road, Hershey, PA, USA.
Amy ZhengPenn State College of Medicine, Penn State Health Milton S. Hershey Medical Center 700 HMC Crescent Road, Hershey, PA, USA.
Mashtura HasanPenn State College of Medicine, Penn State Health Milton S. Hershey Medical Center 700 HMC Crescent Road, Hershey, PA, USA.
Vonn WalterDepartment of Public Health Sciences, Penn State College of Medicine 500 University Drive, Hershey, PA, USA.
Jay G FuletraDepartment of Urology, Penn State Health Milton S. Hershey Medical Center 500 University Drive, Hershey, PA, USA.
Jay D RamanDepartment of Urology, Penn State Health Milton S. Hershey Medical Center 500 University Drive, Hershey, PA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo review 27-years of testicular cancer (TC) incidence data (1990-2017) within the state of Pennsylvania to better define incidence, geographic distribution, and trends over time.

methodsThe Pennsylvania Cancer Registry was reviewed for statewide and component county age-adjusted TC incidence rates and stage distribution. We reported annual percent changes (APCs) in age-adjusted rates. Maps plotting county-level incidence rates across the state in five-year time intervals were created.

resultsIn Pennsylvania, 9,933 TC cases were recorded between 1990-2017. Over two-thirds of patients were < 40 years of age and 95% were White. Approximately 89% presented as local and regional disease. Age-adjusted annual rates of total TC increased from 4.80 to 7.20 patients per 100,000 with an APC of 0.94 (95% Confidence Interval (CI) = (0.59, 1.29), P < 0.01) over the study interval. Annual rates of local disease increased from 3.20 to 5.00 patients per 100,000 with an APC of 1.07 (95% CI = (0.67, 1.46), P < 0.01). Annual rates of distant disease were stable and ranged from 0.50 to 0.80 patients per 100,000 with an APC of 0.69 (95% CI = (-0.02, 1.40), P = 0.06). Geospatial investigation noted increased incidence in urban centers.

conclusionsAlthough TC is rare, incidence is rising. Rates of TC in Pennsylvania almost doubled over the past two decades. Fortunately, this rising trend is primarily attributed to increases in local and regional disease. Counties with higher incidence rates cluster in urban centers which may reflect exposure risk, access to care, or reporting bias.

Indexed as

diagnosisepidemiologystatewide trendsTesticular cancer

Identifiers

PMID37941643
PMCPMC10628630

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.